Amicus Therapeutics, Inc. with ticker code (FOLD) have now 10 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between 20 and 12 suggesting an average Analsyt target price of $15.80. Given that the stocks previous close was at $11.90 and the analysts are correct then there would likely be a percentage uptick in value of 32.8%. The 50 day moving average now sits at $11.45 and the 200 day MA is $11.66. The market capitalization for the company is 3.36B. The stock price is currently at: 11.8 USD
The potential market cap would be $4,458,516,760 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of 1.16 and a -14.07% return on assets.
